Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ ,L/ x\_28
Z4] n<~o
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© CFaY= Cy
9-ozrw
8t
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ntW@Fm:bw>
ShB]U5b:k
1.Co-stimulators (or co-stimulating molecules)
po*G`b;v
Jxe+LG
2.NK-kB c5YPV"X
V_+&Y$msi~
3.Immunoglobulin superfamily cSb;a\el$
Kw
-SOFE
4.antigen-presenting cell (APC) isZ5s
\
8`q7Yss6F
5.death domain vi,hWz8WB
_wq?Pa<)e
6.CCR and CXCR H71sxek3
qlO}=b/
7.Lectin (or mitogen) ks4`h>i
Y2H-D{a27
8.Clusters of differentiation, CD) CXlbtpK2k
d!,t_jM0
9.B7 family 2B,O/3y
{K,In)4
10.Cytotoxic T lymphocyte, CTL) ;P@]7vkff
5~*)3z^V
11.IL-15 and IL-15 receptor (IL-15R) ^jdU4
~3&{`9Y
12.MHC restriction :D.0\.p
&gXh:.
13.Affinity-chromatography Fhoyji4
Yd^@Ei9
14.Cyctosprin A, CsA )pnyVTKt
)#=J<OpG
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) Gz[yD
~6a
.Eao|;
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© HgI!q<)
ccD+AGM.
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ._mep\#.:
.HqFdsm
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ {@Mr7*u
wX$:NOO
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ s{hKl0ds
2-&EkF4p'
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ' W/M>!X
@f!X%)\;x
ÃâÒßѧרҵ£º op,L3:R\Z
QTV*m>D
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ eI
#Gx_mg
=OVDJ0ozZ
Ïû»¯ÄÚ¿Æ£º x&}]8S)
6*OL.~WE
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ l'@-?p(Vuw
cNs'GfD}
ѪҺ²¡Ñ§×¨Òµ£º RaZ>.5
D
c\bL_
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿